Trial Profile
A Randomized Study of Once Daily Fludarabine-Clofarabine Versus Fludarabine Alone Combined With Intervenous Busulfan Followed by Allogeneic Hemopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Antithymocyte globulin; Busulfan; Fludarabine; Methotrexate; Tacrolimus; Tacrolimus
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 16 Dec 2020 Status changed from active, no longer recruiting to completed.
- 04 Dec 2020 Planned End Date changed from 1 Nov 2020 to 1 Dec 2021.
- 04 Dec 2020 Planned primary completion date changed from 1 Nov 2020 to 1 Dec 2020.